InterWell Health, Cricket Health, and Fresenius Health Partners Complete Three-Way Merger, Creating Premier, Value-based Kidney Care Provider
Summary
The transaction has satisfied customary closing conditions and received regulatory clearance in the U.S.The completed merger, first announced in March 2022, positions the new InterWell Health to engage and manage the care of more than 270,000 individuals living with kidney disease in the U.S. Working closely with our physician partners, we will reduce hospital admissions and readmissions, increase transplant referrals and rates, accelerate the transition to home dialysis, and improve health equity. "We are focused on helping patients better navigate the complex and fragmented care delivery system through the identification of opportunities to keep them upstream for longer and ensure that those already living with kidney disease are the biggest beneficiary of this exciting endeavor. "The new InterWell Health is a standalone entity backed by leading investors, including: Fresenius Medical Care; Valtruis, a WCAS company; Oak HC/FT; Cigna Ventures; and Blue Shield of California. The company is differentiated by its ability to deliver improved clinical outcomes and better quality of life for patients, reduce the total cost of care for payer partners, and provide the resources physicians need to thrive in a value-based world all at scale.